Health IT Enhanced for CKD in Safety-Net Primary Care

安全网初级保健中针对 CKD 的健康 IT 增强

基本信息

  • 批准号:
    8335416
  • 负责人:
  • 金额:
    $ 23.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-30 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic kidney disease (CKD) is common in U.S. adults and is associated with excess mortality and morbidity. Better management could slow progression of disease, prevent metabolic complications, and reduce cardiovascular outcomes. However, low patient and provider awareness of CKD, inadequate knowledge of treatment strategies, and ineffective patient-provider communication can impede such efforts. We propose to evaluate an incrementally intensive set of interventions to enhance awareness, improve knowledge, and foster better communication, possibly leading to better clinical outcomes. The interventions, based on the Chronic Care Model and Social Cognitive Theory, will be evaluated in a high-risk, underserved population seeking primary care at 10 community health clinics, using a prospective randomized trial nested in a quasi- experimental study design. In four clinics, we will introduce an automated CKD registry incorporating decision support, which will identify patients with CKD, send notifications to providers, and provide educational materials to patients and providers (Basic CKD Registry). In six additional clinics, we will introduce the Enhanced CKD Registry, which will include all the components of the Basic CKD Registry, augmented with claims-based surveillance of care and care team feedback. We will randomize patients in these six clinics to either 1) the Enhanced CKD Registry intervention or 2) the Enhanced CKD Registry Plus, which includes an additional patient-level intervention: automated telephone calls offering CKD education and self-management support, with need-based follow-up by a health coach who communicates with the care team. We will compare our primary outcome, change in blood pressure, pre- vs. post-implementation of the Basic CKD Registry; between patients in the Enhanced vs. Basic CKD Registry; and between patients in the Enhanced CKD Registry Plus vs. the Enhanced CKD Registry. We will also examine secondary clinical (e.g., albuminuria, HbA1c), intermediate (e.g., awareness, activation, ACE/ARB use), and sustainability (e.g., reach, adoption, maintenance) outcomes. This proposal unites a large safety-net health system for patients at high risk for CKD progression and complications to address barriers to improved CKD management. Successful interventions can be extended throughout our larger healthcare system, on a wider scale in similar safety-net systems, and in patient populations with less complex clinical profiles. Thus, this study has important implications for improving the health status of CKD patients in the United States.
描述(由申请人提供):慢性肾脏疾病(CKD)在美国成年人中很常见,并与过度死亡率和发病率相关。更好的管理可以减缓疾病的进展,预防代谢并发症,减少心血管疾病的发生。然而,患者和提供者对CKD的认识不足,治疗策略知识不足以及患者与提供者沟通不力可能会阻碍这些努力。我们建议评估一套增量密集的干预措施,以提高认识,提高知识,促进更好的沟通,可能会导致更好的临床结果。基于慢性病护理模式和社会认知理论的干预措施将在10个社区卫生诊所寻求初级保健的高风险,服务不足的人群中进行评估,使用嵌套在准实验研究设计中的前瞻性随机试验。在四个诊所中,我们将引入一个包含决策支持的自动化CKD登记系统,该系统将识别CKD患者,向提供者发送通知,并向患者和提供者提供教育材料(基本CKD登记系统)。在另外六家诊所,我们将引入增强型CKD登记系统,该系统将包括基本CKD登记系统的所有组成部分,并增加基于索赔的护理监测和护理团队反馈。我们将在这六个诊所中随机分配患者接受1)增强型CKD登记干预或2)增强型CKD登记+,其中包括额外的患者水平干预:提供CKD教育和自我管理支持的自动电话呼叫,由与护理团队沟通的健康教练进行基于需求的随访。我们将比较我们的主要结局,血压变化,实施基础CKD登记研究前后;增强型CKD登记研究与基础CKD登记研究中的患者之间;增强型CKD登记研究+与增强型CKD登记研究中的患者之间。我们还将检查次要临床(例如,白蛋白尿,HbA 1c),中间(例如,意识、激活、ACE/ARB使用)和可持续性(例如,达到,采用,维护)的结果。该提案为CKD进展和并发症高风险患者建立了一个大型安全网卫生系统,以解决改善CKD管理的障碍。成功的干预措施可以在我们更大的医疗保健系统中推广,在类似的安全网系统中推广,在临床特征不太复杂的患者群体中推广。因此,这项研究对改善美国CKD患者的健康状况具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEIL R. POWE其他文献

NEIL R. POWE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEIL R. POWE', 18)}}的其他基金

Health IT Enhanced for CKD in Safety-Net Primary Care
安全网初级保健中针对 CKD 的健康 IT 增强
  • 批准号:
    8231935
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
Health IT Enhanced for CKD in Safety-Net Primary Care
安全网初级保健中针对 CKD 的健康 IT 增强
  • 批准号:
    8529515
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
ESTABLISHING A SURVEILLANCE SYSTEM FOR CHRONIC KIDNEY DISEASE IN THE U.S.
在美国建立慢性肾脏病监测系统
  • 批准号:
    8504710
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
ESTABLISHING A SURVEILLANCE SYSTEM FOR CHRONIC KIDNEY DISEASE IN THE U.S.
在美国建立慢性肾脏病监测系统
  • 批准号:
    8316461
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
ESTABLISHING A SURVEILLANCE SYSTEM FOR CHRONIC KIDNEY DISEASE IN THE U.S.
在美国建立慢性肾脏病监测系统
  • 批准号:
    8337624
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
ESTABLISHING A SURVEILLANCE SYSTEM FOR CHRONIC KIDNEY DISEASE IN THE U.S.
在美国建立慢性肾脏病监测系统
  • 批准号:
    8727286
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
Retained Organic Solutes and Clinical Outcomes in Hemodialysis
血液透析中残留的有机溶质和临床结果
  • 批准号:
    8113661
  • 财政年份:
    2010
  • 资助金额:
    $ 23.14万
  • 项目类别:
Retained Organic Solutes and Clinical Outcomes in Hemodialysis
血液透析中残留的有机溶质和临床结果
  • 批准号:
    8143276
  • 财政年份:
    2008
  • 资助金额:
    $ 23.14万
  • 项目类别:
Retained Organic Solutes and Clinical Outcomes in Hemodialysis
血液透析中残留的有机溶质和临床结果
  • 批准号:
    8310227
  • 财政年份:
    2008
  • 资助金额:
    $ 23.14万
  • 项目类别:
Retained Organic Solutes and Clinical Outcomes in Hemodialysis
血液透析中残留的有机溶质和临床结果
  • 批准号:
    7931954
  • 财政年份:
    2008
  • 资助金额:
    $ 23.14万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 23.14万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了